Transferrin and gonadal dysfunction in man.
Transferrin concentrations were quantitated in the seminal fluid of normal, oligozoospermic, and azoospermic patients and related to other known parameters of testicular function. Transferrin concentration in the semen of patients 2 months after vasectomy (13.2 +/- 1.8 micrograms/ml) was significantly less than that obtained from pregnancy-proven donors (65.6 +/- 10.1 micrograms/ml). This indicates that approximately 80% of the seminal fluid transferrin is derived from the testes. The concentration of transferrin in semen from patients with azoospermia (14.4 +/- 1.8 micrograms/ml), severe oligozoospermia (17.5 +/- 1.7 micrograms/ml), and moderate oligozoospermia (21.8 +/- 4.3 micrograms/ml) was significantly lower than normospermic groups. Serum follicle-stimulating hormone (FSH) was measured in a group of infertile patients; those having an elevated FSH had a significantly lower concentration of semen transferrin, 14.1 +/- 1.6 micrograms/ml, compared with patients who had FSH levels within the normal range (33.7 +/- 5.3 micrograms/ml). It is possible that the underlying cause in decreased spermatogenesis associated with both an elevated FSH and a decreased transferrin concentration is impaired Sertoli cell function.
D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007248:Infertility, Male / Q000209:etiology / Q000378:metabolism*; D008297:Male; D009845:Oligospermia / Q000378:metabolism; D012661:Semen / Q000032:analysis*; D012708:Sertoli Cells / Q000378:metabolism*; D013733:Testicular Diseases / Q000175:diagnosis / Q000378:metabolism; D014168:Transferrin / Q000032:analysis*
D014168:Transferrin; D005640:Follicle Stimulating Hormone